Combination therapy offers breakthrough in NSCLC treatment

A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from The University of Texas MD Anderson Cancer Center.

Pharmalittle: CRISPR pioneers reflect on future of gene editing; U.K. and pharma reach deal on how NHS pays for drugs

Good morning and welcome to Thanksgiving week! STAT reporter Andrew Joseph here filling in for Mr. Pharmalot today. It’s my first Thanksgiving since moving over

November 20, 2023

The kidney, in all its complexity, is captured in an atlas that could aid disease research

The kidneys are some of the most architecturally complex organs in the human body — intricate in a way that becomes frustrating when, for millions

July 19, 2023

Vitamin D deficiency linked to increased dementia risk, supplements may help

Study in the UK Biobank cohort found vitamin D deficiency and insufficiency significantly increase the risk of dementia, Alzheimer’s, and vascular dementia, with supplementation potentially

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.